Avidity Partners Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-64,501	Closed	-$949K	–	90
2023 Q4	$949K	Sell	64,501 -1,692,439	-96%	-$24.9M	0.03%	70
2023 Q3	$32.2M	Buy	1,756,940 +855,540	+95%	+$15.7M	1.3%	37
2023 Q2	$19.4M	Buy	901,400 +1,400	+0.2%	+$30.2K	0.68%	53
2023 Q1	$26.4M	Buy	+900,000	New	+$26.4M	0.88%	40